All lobbying filings
Frontline Government Relations
Frontline Government Relations filed a Q3 report for Empower Pharmacy on October 16, 2026, reporting $7,500 in lobbying income.
Lobbying for Empower Pharmacy · Compounding pharmacy
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 16, 2026
Income
$7,500
What the client paid this registrant for the period.
Client based in
Texas
Government bodies contacted
4
Lobbying activity
2
Advocated for regulatory clarity and proportional enforcement in the oversight of outsourcing facility manufacturing under Section 503B of the Federal Food, Drug, and Cosmetic Act.
Advocated for clarity and fairness in the regulation of pharmaceutical compounding by the Food and Drug Administration (FDA), including issues related to compliance with Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.